The Claim

E2HSA administration results in a dose-dependent reduction in food intake in healthy rhesus monkeys, suggesting an effect on appetite regulation that may contribute to its observed metabolic benefits.

Source: A novel exendin-4 human serum albumin fusion protein, E2HSA, with an extended half-life and good glucoregulatory effect in healthy rhesus monkeys.

What the research says

Roughly balanced

Support and challenge are close. The picture may shift as more studies come in.

Supports
6score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

This drug called E2HSA seems to make monkeys eat less the more they get, which might help control their appetite and improve their metabolism.

See the scientific wording

E2HSA dose-dependently suppresses food intake in healthy rhesus monkeys, indicating an effect on appetite regulation that may contribute to its metabolic benefits.

What the research says

1 study

  1. Study: A novel exendin-4 human serum albumin fusion protein, E2HSA, with an extended half-life and good glucoregulatory effect in healthy rhesus monkeys.

    The study tested E2HSA in monkeys and found that the more they gave, the less the monkeys ate, which matches the claim exactly.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.